Utah Medical Products Files Q1 2026 Results and Forward Guidance

What Happened

• Utah Medical Products, Inc. (UTMD) filed a Form 8‑K on April 23, 2026 to furnish financial information for the three months ended March 31, 2026.
• The filing incorporates a press release dated April 23, 2026 that includes the company’s quarterly financial information and forward‑looking statements relating to 2026 and beyond (filed as Exhibit 99.1).

Key Details

• The financial information covers the quarter ended March 31, 2026.
• Forward‑looking statements about 2026 and future periods are included in the April 23, 2026 press release.
• The press release is attached to the 8‑K as Exhibit 99.1 and is explicitly incorporated by reference in the report.
• Reported under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).

Why It Matters

• This filing gives investors the company’s first-quarter 2026 results and management’s near‑term expectations, which are key for assessing revenue and earnings trends and setting expectations for future quarters.
• The incorporated press release (Exhibit 99.1) is the primary source for the detailed numbers and any guidance; investors should read that release for specific revenue, earnings, or guidance figures.